Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00001208

Botulinum Toxin for the Treatment of Involuntary Movement Disorders

Botulinum Toxin for the Treatment of Neurological Disorders

Status
Recruiting
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS) · NIH
Sex
All
Age
2 Years – 100 Years
Healthy volunteers
Not accepted

Summary

BTX has been used since the 1980s in support of the research mission of NINDS. Initial studies were focused on expanding the applicability of BTX treatment to movement disorders and exploring new indications. We evaluated the efficacy of an alternative serotype, type F. Under other protocols, we continue to study the physiology of movement disorders and BTX response. The application of BTX therapy to movement disorders requires an understanding of BTX preparation and handling. The treatment must be tailored to the disorder under treatment and to its expression in the individual patient. Users must know the specific techniques of injection, including the use of EMG and ultrasound guidance. This protocol allows us to train physicians in all aspects of the use of BTX. It also provides us with a cohort of patients, receiving a standard method of treatment and with a stable response to BTX injection, for participation in other protocols on movement disorders and on the responses to BTX injection.

Detailed description

The efficacy of botulinum toxin (BTX) has now been demonstrated for a variety of diseases associated with involuntary muscles spasms or movement. The application of botulinum toxin therapy to movement disorders requires treatment tailored to the individual patient and specific techniques of injection. This protocol 1) allows us to follow the natural history of subjects with movement disorders who receive standard botox injections for treatment of movement disorders and 2) allows us to provide botulinum toxin injections for patients participating in other NIH studies.

Conditions

Timeline

Start date
1989-10-26
First posted
1999-11-04
Last updated
2026-03-31

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00001208. Inclusion in this directory is not an endorsement.